
    
      This is an open-label, prospective, 1:1 randomized, parallel-group, study to evaluate the
      safety and efficacy of Expanded Hemodialysis (HDx) compared to hemodiafiltration (HDF) in
      patients with chronic kidney disease in Spain for up to 36 months.

      Stable incident hemodialysis patients from hemodialysis in-hospital units and related
      satellite centers in Spain.
    
  